Stage IVA Colorectal Cancer Recruiting Phase 3 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0068496 (Stage IVA Colorectal Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02997228Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal CancerTreatment